TARBOD Trademark

Trademark Overview


On Monday, March 14, 2022, a trademark application was filed for TARBOD with the United States Patent and Trademark Office. The USPTO has given the TARBOD trademark a serial number of 97312018. The federal status of this trademark filing is REGISTERED as of Tuesday, January 21, 2025. This trademark is owned by Booster Therapeutics GmbH. The TARBOD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases, heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases; Compound drugs and pharmaceuticals for the use in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders to treat the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunct...
tarbod

General Information


Serial Number97312018
Word MarkTARBOD
Filing DateMonday, March 14, 2022
Status700 - REGISTERED
Status DateTuesday, January 21, 2025
Registration Number7656979
Registration DateTuesday, January 21, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases, heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases; Compound drugs and pharmaceuticals for the use in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders to treat the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, by degrading disease-causing cellular proteins; Compound drugs and pharmaceuticals for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, by degrading disease-causing cellular proteins

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBooster Therapeutics GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBerlin D-10629
DE

Party NameBooster Therapeutics GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBerlin D-10629
DE

Party NameBooster Therapeutics GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBerlin D-10629
DE

Trademark Events


Event DateEvent Description
Thursday, March 17, 2022NEW APPLICATION ENTERED
Friday, March 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 23, 2022ASSIGNED TO EXAMINER
Saturday, March 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 28, 2022NON-FINAL ACTION WRITTEN
Wednesday, December 28, 2022NON-FINAL ACTION E-MAILED
Wednesday, December 28, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 14, 2023SUSPENSION LETTER WRITTEN
Friday, April 14, 2023LETTER OF SUSPENSION E-MAILED
Friday, April 14, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, December 22, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, October 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 24, 2024ASSIGNED TO LIE
Thursday, October 24, 2024ASSIGNED TO LIE
Tuesday, November 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, January 21, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, July 19, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED